Introducing Elarex

A new healthcare technology company with a mission to stabilize biologicals, especially vaccines.

The Elarex PT120 Formulation Technology has many merits. The most startling? Live attenuated vaccines formulated with PT120 have equivalent performance after storage at 40C as unformulated vaccine stored at -80C. That's 120 degrees of stabilization. The final product form is highly customizable including powders and coatings. We aim to partner with vaccine leaders, to help improve your products. Our vision is a future where vaccines will not need refrigeration. Visit us on LinkedIn below to learn more.